18
Views
9
CrossRef citations to date
0
Altmetric
Research Article

THE EFFECT OF DIPYRONE ON SURVIVAL OF SKIN FLAPS

Pages 19-22 | Published online: 08 Jul 2009

References

  • Edstrom LE, Balkovich M, Slotman GJ. Effect of ischemic skin flap elevation on tissue and plasma thromboxane A-2 and prostacyclin production: modification by thromboxane synthetase inhibi-tion. Ann Plast Surg 1988; 20: 106–111.
  • Ergifigen AR, Apaydin I, Emiroglu M, Gillian SM, Ergiin H, Yormuk E. The effects of L-arginine and iloprost on the viability of random skin flaps in rats. Scand J Plast Reconstr Surg Hand Surg 1998; 32: 19–25.
  • Ergiin H, Ayhan III, Tulunay FC. Pharmacolo-gical characterization of metamizol-induced relaxation in phenylephrine-precontracted rabbit thoracic aorta smooth muscle. Gen Pharmacol 1999; 33: 237–241.
  • Finseth F, Adelberg MG. Prevention of skin flap necrosis by a course of treatment with vasodilator drugs. Plast Reconstr Surg 1978; 61: 738–743.
  • Finseth F, Cutting C. An experimental neurovas-cular island flap for the study of the delay phenomenon. Plast Reconstr Surg 1978; 61: 412–420.
  • Galla TJ, Saetzer RKE, Hammersen F, Messmer K. Increase in skin-flap survival by the vasoac-five drug buflomedil. Plast Reconstr Surg 1991; 87: 130–136.
  • Höft HID, Oswald P, Tilgner A, Schuman D. Can chlorpromazine prevent flap necrosis?. Br J Plast Surg 1990; 43: 587–589.
  • Jurell G. Adrenergic nerves and the delay phenomenon. Ann Plast Surg 1986; 17: 493–496.
  • Kerrigan CL, Daniel RK. Critical ischaemia time and the failing skin flap. Plast Reconstr Surg 1982; 69: 986–989.
  • Kerrigan CL, Daniel RK. Pharmacologic treat-ment of failing skin flap. Plast Reconstr Surg 1982; 70: 541–548.
  • Kjartansson J, Dalsgaard CJ, Jonsson CE. Decreased survival of experimental critical flaps in rats after sensory denervation with capsaicin. Plast Reconstr Surg 1987; 79: 218–221.
  • Levy M, Zylber-Kaltz E, Rosenkranz B. Clinical pharmacokinetics of dipyrone and its metabo-lites. Clin Pharmacokinet 1995; 28: 216–234.
  • Misholy H, Jacobs G, Reinisch JF, Puckett CL. A grid method for evaluating flap survival in rats. Plast Reconstr Surg 1982; 69: 881–882.
  • Myers B, Guber M, Donovan W. The fluores-cence camera: how to use fluorescein dye in a normally illuminated room. Ann Plast Surg 1983; 10: 248–251.
  • Pal S, Khazanchi RK, Moudgil K. An experi- mental study on the effect of nifedipine on ischaemic skin flap survival in rats. Br J Plast Surg 1991; 44: 299–301.
  • Pang CY, Chiu C, Zhong A, Xu Ning. Pharma-cologic intervention of skin vasospasm and ischaemic necrosis in pigs. J Cardiovasc Phar-macol 1993; 21: 163–171.
  • Pang CY, Forrest CR, Morris SF. Pharmacologi-cal augmentation of skin flap viability: a hypoth-esis to mimic the surgical delay phenomenon or a wishful thought. Ann Plast Surg 1989; 22: 293–306.
  • Pang CY, Neligan PC, Forrest CR, Nakatsuka T, Sasaki GH. Hemodynamics and vascular sensi-tivity to circulating norephinephrine in normal skin and delayed and acute random skin flaps in the pig. Plast Reconstr Surg 1986; 78: 75–84.
  • Patel C, Marsili A, Sykes PJ. Augmentation of flap survival by thymoxamine. Br J Plast Surg 1982; 35: 88–91.
  • Price MA, Pearl RM. Multiagent pharmacother-apy to enhance skin flap survival: lack of additive effect of nitroglycerin and allopurinol. Ann Plast Surg 1994; 33: 52–56.
  • Ramasastry SS, Waterman P, Angel MF, Futrell JW. Effect of fluosol-DA (20%) on skin flap survival in rats. Ann Plast Surg 1985; 15: 436–442.
  • Rohrich RJ, Cherry GW, Spira M. Enhancement of skin-flap survival using nitroglycerin oint-ment. Plast Reconstr Surg 1984; 73: 943–948.
  • Tane N, Inoue H, Aihara M, Ishida H. The effects of endothelin-1 on flap necrosis. Ann Plast Surg 1995; 35: 389–395.
  • Uhl E, Rosken F, Curri SB, Menger MD, Messmer K. Reduction of skin flap necrosis by transdermal application of buflomedil bound to liposomes. Plast Reconstr Surg 1998; 102: 1598–1604.
  • Welch JD. The photography of fluorescein. Plast Reconstr Surg 1982; 69: 990–994.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.